MedTrace Logo

OTC Mouthpiece for Snoring

NCT03128307 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 604

Last updated 2017-12-14

Study results available
· View outcomes & findings →

Summary

Online patient registration to participate in clinical trial to test OTC mouthpiece that controls position of the tongue to reduce snoring.

Conditions

  • Snoring

Interventions

DEVICE

Zyppah Anti-snoring Appliance

Use of an OTC mouth guard at night to prevent snoring

Sponsors & Collaborators

  • Zyppah, Inc.

    lead INDUSTRY

Principal Investigators

  • Jonathan Greenburg, DDS · Zyppah, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-07
Primary Completion
2017-05-03
Completion
2017-08-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03128307 on ClinicalTrials.gov